Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J's TMC435 Joins The Pharmasset Club

Jul 06 2011

• By Jessica Merrill

Related Content

Bristol, Pharmasset To Study Oral HCV Regimen Together

Jan 10 2011

Vertex Prepares For HCV Combo Research By Licensing Two Compounds From Alios

Jun 13 2011

EASL Preview: Dual Versus Quad Combinations

Mar 07 2011

Vertex Prices Telaprevir At $49,200 For Course Of Therapy

May 23 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window